| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |